oa Intravitreal Injection of Triamcinolone Acetonide for the Treatment of Refractory Diabetic Macular Edema

References

1. Klein R, Klein E, Moss SE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy, IV: diabetic macular edema. Ophthalmology. 1984; 91::1464–1474.
   [Google Scholar]
2. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol. 1985; 103::1796–1806.
   [Google Scholar]
3. Lee CM, Oik RJ. Modified grid laser photocoagulation for diffuse diabetic macular edema. Long term visual results. Ophthalmology. 1991; 98::1594–1602.
   [Google Scholar]
4. Antcliff RJ, Spalton DJ, Stanford MR. Intravitreal Triamcinolone Acetonide for uveitic cystoid macular edema: An optical coherence tomography study. Ophthalmology. 2001; 108::765–772.
   [Google Scholar]
5. Nauck M, Roth M, Tamm M. Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids. Am J Respir Cell Mol Biol. 1997; 16::398–406.
   [Google Scholar]
6. Antonetti DA, Barber AJ, Hollinget LA. Vascular endothelial growth factor induces rapid phosphorylation of tight junctions proteins occludin and zonula occluden 1. J Biol Chem. 1999; 274::23463–23467.
   [Google Scholar]
7. Bresnich GH. Diabetic maculopathy: A critical review highlighting diffuse macular edema. Ophthalmol. 1983; 90::1301–1307.
   [Google Scholar]
8. Bresnick GH. Diabetic macular edema: A review. Ophthalmol. 1986; 93::989–997.
   [Google Scholar]
9. Gillies MC, Su T, Stayt J. Effect of high glucose on permeability of retinal capillary endothelium. Invest Ophthalmol Vis Sci. 1997; 38::635–641.
   [Google Scholar]
10. Gardner TW, Lieth E, Khin SA. Astrocytes increases barrier properties and ZO-1 expression in retinal vascular endothelial cells. Invest Ophthalmol Vis Sci. 1997; 38::2423–2427.
    [Google Scholar]
11. Wallow IHL, Engerman RL. Permeability and patency of retinal blood vessels in experimental diabetes. Invest Ophthalmol Vis Sci. 1977; 16::447–460.
    [Google Scholar]
12. Vinores SA, Niel EV, Swerdorff JL. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats. Exp Eye Res. 1993; 57::723–735.
    [Google Scholar]
13. Ashton N. Studies of the retinal capillaries in relation to diabetic and other retinopathies. Br J Ophthlamol. 1963; 47::521–538.
    [Google Scholar]
14. Cogan DG, Toussaint D, Kubawara T. Retinal vascular patterns. Arch Ophthalmol. 1961; 66::100–112.
    [Google Scholar]
15. Krupin T, Waltman SR, Szewczyck P. Fluorometric studies on the blood-retinal barrier in experimental animals. Arch Ophthalmol. 1982; 100::631–634.
    [Google Scholar]
16. Wilson CA, Berkowitz BA, Sato Y. Treatment with intravitreal steroids reduces blood-retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol. 1992; 110::1155–1159.
    [Google Scholar]
17. Jonas JB, Sofker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthlamol. 2001; 132::425–427.
    [Google Scholar]
18. Martidis A, Duekr JS, Greenberg PB. Intravitreal Triamcinolone for refractory diabetic macular edema. Ophthlamology. 2002; 109::920–927.
    [Google Scholar]
19. Jonas JB, Kreissig I, Sofker A. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthlamol. 2003; 121::57–61.
    [Google Scholar]
20. Chieh JJ, Roth DB, Liu M. Intravitreal triamcinolone acetonide for diabetic macular edema. Retina. 2005; 25::828–834.
    [Google Scholar]
21. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol. 2003; 87::24–27.
    [Google Scholar]
22. Roth DB, Chieh JJ, Spirn MJ. Non-infectiuos endohthalmitis associated with intravitreal triamcinolone injection. Arch Ophthlamol. 2003; 121::1279–1282.
    [Google Scholar]
23. Jonas JB, Hayer JR, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreo-retinopathy. Br J of Ophthalmol. 2000; 84::1064–1067.
    [Google Scholar]